How can we identify candidates at highest risk - to screen or not to screen? Article

Barengo, NC, Tuomilehto, JO. (2016). How can we identify candidates at highest risk - to screen or not to screen? . HERZ, 41(3), 175-+. 10.1007/s00059-016-4417-5

International Collaboration

keywords

  • Advantages
  • CARDIOVASCULAR RISK
  • CONTROLLED-TRIAL
  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Disadvantages
  • EUROPEAN-SOCIETY
  • FASTING GLUCOSE
  • FOLLOW-UP
  • Harms
  • IMPAIRED GLUCOSE-TOLERANCE
  • LIFE-STYLE INTERVENTION
  • Life Sciences & Biomedicine
  • PREVENTION
  • PSYCHOLOGICAL IMPACT
  • Science & Technology
  • Screening
  • TYPE-2 DIABETES-MELLITUS
  • Type 2 diabetes

Digital Object Identifier (DOI)

publisher

  • URBAN & VOGEL

start page

  • 175

end page

  • +

volume

  • 41

issue

  • 3